Patent · US Active

Use of peptide for treating angiogenesis-related diseases

US9925238B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Inventors

Chi-Sheng Lu · Taipei, TW
Hung-I Yeh · Taipei, TW
Min-Che Chen · Amherst, US
Chun-Wei Chen · Hsinchu, TW

Key dates

Filing date	Apr 29, 2015
Grant date	Mar 27, 2018
Priority date	—
Expiry date	Apr 29, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods for treating an angiogenesis-related condition or disease in a subject in need thereof. Said method includes administering to the subject a peptide having at least 90% sequence identity of the sequence of SEQ ID NO: 1 or SEQ ID NO:3 in a therapeutically effective amount.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.